News

EGF BIOeffectTM Serum chosen one of 5 most exciting innovations at in-cosmetics in Paris

30.4.2010
The EGF BIOeffectTM Serum, produced and marketed by SIF Cosmetics, has been selected by The Independent, as one of the five most exciting innovations at the international in-cosmetics exhibition held in Paris, 13-15 April.

Pre-launch of EGF BIOeffect™ and EGF BIOeffect™ plús in Iceland

10.2.2010
Sif Cosmetics will launch its first product line, the EGF BIOeffect Serum and EGF BIOeffect Serum plús, in Iceland. A pre-launch by special invitation only will be held in the Nordic House on February 24th. A special invitation will be sent to the participants of the EGF BIOeffect Serum survey conducted by Sif Cosmetics in December and January.

Results of a survey of EGF BIOeffect™ Serum and EGF BIOeffect™ Serum plús

4.2.2010
More than 100 volenteers participated in a survey conducted by Sif Cosmetics to evaluate the company‘s first product line, EGF BIOeffect Serum. The participants applied EGF BIOeffect Serum and EGF BIOeffect Serum plús to face and neck after cleansing every night for a period of 1-6 weeks. Around 70% responded to a short web-survey giving feedback on the use and effectivity of the Serum. A full report will be available shortly.

INCI name approval for KGF BIOeffect™

1.2.2010
Sif Cosmetics has obtained an INCI name for its peptide KGF BIOeffect™ assigned by the International Nomenclature Committee. The assigned INCI Name is:  Transgenic Barley sh-Polypeptide-3 (and) Transgenic Barley Seed Extract.

Sif Cosmetics moves headquarters to new facilities

16.12.2009
Sif Cosmetics has now moved its headquarters to Víkurhvarf 3, Kópavogur. The company has been based in Keldnaholt in Reykjavík, but will now move to new and custom-made facilities in Kópavogur, which is in the greater Reykjavík area.

Successful show at ECAAAM-Mainz 2009

19.10.2009
Sif Cosmetics exhibited at the European Congress on Anti-Aging and Aesthetic Medicine October 14-17. The conference and show proved an effective platform for networking and connecting with professionals in anti-aging medicine mainly in Germany, and strengthend our belief that Sif Cosmetics has exciting prospects in the field of cosmeceuticals.

Meet us at the European Congress on Anti-aging & Aesthetic Medicine 2009

13.10.2009

Sif Cosmetics will exhibit at the European Congress on Anti-Aging & Aesthetic Medicine 2009 in Mainz near Frankfurt in Germany. Presenting the company product portfolio at Stand 2008, our staff welcomes guests to learn more about our products. Sif Cosmetics has a limited number of free access passes to the exhibition. Please contact us before the exhibition if you are interested in participating by our invitiation.

First INCI name approval

1.10.2009

Sif Cosmetics has received an INCI name approval for its first product, EGF BIOeffect Serum after registering the EGF product with the U.S. Personal Care Products Counsil. An INCI name has been assigned to the product which enables marketing and selling of the product internationally.
EGF is the first product to be developed and produced but Sif Cosmetics will apply for INCI name registrations for more products containing other exiting growth factors in the coming months.

Sif Cosmetics premiered at in-cosmetics 2009 and returns to the show in 2010

22.6.2009
Sif Cosmetics had a successful exhibition at in-cosmetics 2009 in Munich, Germany. Chosen for the company’s first public appearance, in-cosmetics was a perfect venue to present this new daughter company of ORF Genetics to the cosmetics industry. Sif Cosmetics will return to In-cosmetics 2010, staged in Paris, 13-15 April.

Sif Cosmetics and Ronald L. Moy sign business agreement

5.6.2009

Sif Cosmetics and Ronald L. Moy, MD. Inc. have signed a business agreement based on their cooperation on developing anti-aging facial products. The products include growth factors produced by ORF Genetics as active ingredients. Growth factors are proteins that are necessary for stimulating the production and maintenance of cells and have been identified as one of the most exciting breakthroughs in skin-care. Ronald L. Moy, MD. Inc. will start selling the products under its own brand name in its clinics in the USA as early as the third quarter of 2009.
ORF